These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11396980)

  • 1. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.
    Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS
    Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
    Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of FHIT expression in gastric carcinoma.
    Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
    Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
    Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
    Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas.
    Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHIT gene in gastric cancer: association with tumour progression and prognosis.
    Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
    J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the FHIT gene in human oral carcinogenesis.
    Tanimoto K; Hayashi S; Tsuchiya E; Tokuchi Y; Kobayashi Y; Yoshiga K; Okui T; Kobayashi M; Ichikawa T
    Br J Cancer; 2000 Feb; 82(4):838-43. PubMed ID: 10732756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
    Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC
    Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of fragile histidine triad gene (FHIT) with susceptibility to esophageal cancer. A preliminary study].
    Li W; Wang X; Cheng G
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):258-60. PubMed ID: 10920977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.